Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (989)

« Back to Publications

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease

Camera V. et al, (2026), Annals of Clinical and Translational Neurology

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors

Yeh WZ. et al, (2026), Multiple Sclerosis Journal, 32, 794 - 805

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI

Mendelsohn Z. et al, (2026), Neuroradiology

Congenital myasthenic syndrome: is it time for a name change to genetic myasthenic syndrome?

Ramdas S. et al, (2026), Brain, 149, 1816 - 1818

The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice

Arun T. et al, (2026), Practical Neurology

Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study

Attfield KE. et al, (2026), The Lancet Neurology, 25, 482 - 491

Structure–function multilayer network integration and cognition in multiple sclerosis

Breedt LC. et al, (2026), Network Neuroscience, 10, 400 - 417

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors.

Yeh WZ. et al, (2026), Mult Scler

Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple Sclerosis

Colman J. et al, (2026), Human Brain Mapping, 47

Prediction of relapse in myelin oligodendrocyte glycoprotein antibody-associated disease: external validation of the MOG-AR score

Yeh WZ. et al, (2026), Journal of Neurology, 273

Myasthenic syndromes: mistaking genetic for acquired

Henehan L. et al, (2026), Practical Neurology, 26, 164 - 168

Predictive factors for immunosuppression-associated severe and opportunistic infections in AQP4-IgG Neuromyelitis Optica Spectrum Disorder

Greco G. et al, (2026), Multiple Sclerosis Journal, 32, 326 - 337

Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica

Salih H. et al, (2026), Annals of Clinical and Translational Neurology, 13, 581 - 592

Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression

Kacerova T. et al, (2026), Communications Medicine, 6

Optimal strategies for treatment discontinuation in MOG antibody-associated disease

Yeh WZ. et al, (2026), Brain

Load More

1
2
3
4
5
6
7
...
»